Detalles de la búsqueda
1.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420467
2.
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Cancer Immunol Immunother
; 68(4): 609-618, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30721341
3.
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).
J Neurooncol
; 144(2): 303-311, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392595
4.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29645086
5.
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
J Neurooncol
; 140(2): 317-328, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30073642
6.
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Lancet Oncol
; 17(10): 1374-1385, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27592805
7.
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
Cancer Invest
; 34(5): 213-9, 2016 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27127841
8.
A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
J Neurooncol
; 129(2): 281-8, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27311730
9.
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.
Cancer
; 121(19): 3481-90, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26177599
10.
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 463-71, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25707361
11.
Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Clin Adv Hematol Oncol
; 10(4): 240-6, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22706484
12.
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414862
13.
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies.
Clin Cancer Res
; 25(1): 90-98, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30201761
14.
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Front Oncol
; 9: 624, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355141
15.
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.
Clin Cancer Res
; 25(3): 928-936, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30037818
16.
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
Lung Cancer
; 118: 6-12, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572004
17.
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
J Immunother Cancer
; 6(1): 7, 2018 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29347993
18.
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
Lung Cancer
; 113: 79-84, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110854
19.
Clinical impact of checkpoint inhibitors as novel cancer therapies.
Drugs
; 74(17): 1993-2013, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344022
20.
Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium.
Melanoma Res
; 23(6): 468-73, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23969699